Charles L White Selected Research

Charles L White Research Topics

Disease

15	Tauopathies 05/2024 - 04/2012
15	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 04/2004
14	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 10/2006
11	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 10/2006
10	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 10/2006
6	Dementia (Dementias) 11/2022 - 12/2003
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2010
5	Neoplasms (Cancer) 10/2017 - 01/2005
5	Motor Neuron Disease (Primary Lateral Sclerosis) 03/2014 - 07/2007
4	Atrophy 10/2022 - 12/2014
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 03/2007
3	Hemorrhage 09/2004 - 04/2004
2	Synucleinopathies 10/2023 - 01/2022
2	Inflammation (Inflammations) 09/2023 - 01/2018
2	Craniocerebral Trauma (Head Injury) 10/2022 - 04/2004
2	Multiple System Atrophy 10/2022 - 07/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 01/2022
2	Amyloid Plaque 10/2021 - 04/2004
2	Corticobasal Degeneration 11/2019 - 08/2012
2	Astrocytoma (Pilocytic Astrocytoma) 03/2014 - 05/2003
2	Oligodendroglioma 03/2014 - 05/2003
2	Near Drowning 04/2004 - 03/2003
2	Asphyxia (Suffocation) 04/2004 - 03/2003
2	Spinal Cord Injuries (Spinal Cord Injury) 04/2004 - 02/2003
2	Sudden Infant Death (SID) 04/2004 - 03/2003
2	Wounds and Injuries (Trauma) 03/2003 - 02/2003
1	Pick Disease of the Brain (Pick's Disease) 05/2024
1	Macular Degeneration (Age-Related Maculopathy) 12/2023
1	Mixed Dementias 11/2022
1	Virus Diseases (Viral Diseases) 10/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2022
1	Cerebellar Ataxia (Dysmetria) 10/2022
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2022
1	Parkinsonian Disorders (Parkinsonism) 10/2022
1	Striatonigral Degeneration 10/2022
1	Rupture 01/2022
1	Cognitive Dysfunction 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Mental Disorders (Mental Disorder) 01/2021
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2020
1	Hypoxia (Hypoxemia) 12/2019
1	Meningioma (Meningiomas) 12/2019
1	limbic-predominant age-related TDP-43 encephalopathy 01/2019
1	Vascular System Injuries 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Glioma (Gliomas) 01/2018
1	Sclerosis 01/2018
1	Vasculitis (Vasculitides) 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Dermatomyositis (Dermatopolymyositis) 01/2018
1	Adenoma (Adenomas) 10/2017
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 09/2017
1	Granuloma 01/2017

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2023 - 04/2004
10	tau Proteins (tau Protein)IBA 05/2024 - 04/2012
10	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2019 - 07/2007
10	ProgranulinsIBA 01/2018 - 10/2006
9	Amyloid beta-PeptidesIBA 09/2023 - 04/2004
6	Apolipoproteins E (ApoE)IBA 12/2023 - 01/2019
6	SynucleinsIBA 10/2023 - 12/2010
6	Amyloid (Amyloid Fibrils)IBA 10/2021 - 04/2004
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2014
5	UbiquitinIBA 07/2010 - 10/2006
3	Hematoxylin (Haematoxylon)IBA 03/2014 - 04/2004
3	Eosine Yellowish-(YS) (Eosin)IBA 03/2014 - 04/2004
3	Phosphotransferases (Kinase)IBA 02/2014 - 04/2012
2	Protein Isoforms (Isoforms)IBA 05/2024 - 04/2023
2	alpha-SynucleinIBA 10/2022 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2011
2	polyglutamineIBA 01/2020 - 03/2009
2	Complement System Proteins (Complement)IBA 01/2017 - 07/2010
2	AntibodiesIBA 09/2015 - 05/2006
2	Indicators and Reagents (Reagents)IBA 09/2015 - 04/2004
2	moesinIBA 03/2015 - 04/2014
2	Ataxin-2IBA 10/2014 - 08/2011
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2012 - 04/2012
2	Technetium Tc 99m Exametazime (Ceretec)FDA Link 01/2011 - 07/2006
2	Valosin Containing ProteinIBA 07/2007 - 07/2007
2	Antipsychotic Agents (Antipsychotics)IBA 03/2007 - 12/2003
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 10/2004 - 04/2004
1	ORALIT (ORS)IBA 05/2024
1	AutoantibodiesIBA 10/2022
1	Apolipoprotein E3IBA 01/2022
1	Ribonucleases (Ribonuclease)IBA 01/2022
1	GalactosidesIBA 01/2022
1	Apolipoprotein E4IBA 10/2021
1	Naphazoline (All Clear)FDA LinkGeneric 12/2019
1	Carbonic Anhydrase IXIBA 12/2019
1	HLA-DQA2 antigenIBA 01/2019
1	Histones (Histone)IBA 01/2018
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 10/2017
1	HLA-B Antigens (HLA-B)IBA 10/2017
1	Semaphorin-3AIBA 10/2017
1	Periodic AcidIBA 01/2017
1	morinIBA 01/2017

Therapy/Procedure

5	Therapeutics 05/2024 - 07/2004
2	Denervation 01/2020 - 01/2018
1	Immunotherapy 10/2017